TW200509987A - Use of PVP-iodine liposomes for treatment of Herpes - Google Patents

Use of PVP-iodine liposomes for treatment of Herpes

Info

Publication number
TW200509987A
TW200509987A TW093103917A TW93103917A TW200509987A TW 200509987 A TW200509987 A TW 200509987A TW 093103917 A TW093103917 A TW 093103917A TW 93103917 A TW93103917 A TW 93103917A TW 200509987 A TW200509987 A TW 200509987A
Authority
TW
Taiwan
Prior art keywords
treatment
herpes
pvp
iodine liposomes
liposomes
Prior art date
Application number
TW093103917A
Other languages
English (en)
Inventor
Karen Reimer
Wolfgang Fleischer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of TW200509987A publication Critical patent/TW200509987A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
TW093103917A 2003-02-24 2004-02-18 Use of PVP-iodine liposomes for treatment of Herpes TW200509987A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03003282A EP1449520A1 (en) 2003-02-24 2003-02-24 Use of PVP-Iodine liposomes for treatment of herpes

Publications (1)

Publication Number Publication Date
TW200509987A true TW200509987A (en) 2005-03-16

Family

ID=32731523

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093103917A TW200509987A (en) 2003-02-24 2004-02-18 Use of PVP-iodine liposomes for treatment of Herpes

Country Status (7)

Country Link
US (4) US20060240089A1 (zh)
EP (3) EP1449520A1 (zh)
JP (1) JP2006518719A (zh)
AR (1) AR043246A1 (zh)
TW (1) TW200509987A (zh)
UY (1) UY28197A1 (zh)
WO (1) WO2004073682A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1449533A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-iodine liposomes for the treatment of acne
FR2887457B1 (fr) * 2005-06-23 2007-10-05 Fond Bettencourt Schueller Vaccination par ciblage transcutane
ATE449617T1 (de) * 2006-02-02 2009-12-15 Euro Celtique Sa Hydrogel für wundbehandlung
CN102335142B (zh) * 2011-10-25 2014-03-26 上海理工大学 一种能够原位自组装成难溶药物的纳米脂质体的复合微球及其制备方法
JP6122035B2 (ja) * 2012-02-17 2017-04-26 ヴェローチェ・バイオファーマ・エルエルシー 皮膚および爪の治療のための抗真菌組成物
CA2973725A1 (en) * 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use
WO2019005643A1 (en) * 2017-06-26 2019-01-03 Next Science IP Holdings Pty Ltd METHOD OF TREATING PATHOLOGIES OF COLLAGEN FIBERS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
DE4030341A1 (de) * 1990-09-26 1992-04-02 Hans Dr Kiefer Verwendung von pvp-jod enthaltenden mitteln zur lokalen behandlung der blaeschenkrankheit
DE9312509U1 (de) 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
DE29923848U1 (de) * 1998-05-27 2001-04-12 Euroceltique S.A., Luxemburg/Luxembourg Präparate zur Anwendung von entzündungshemmenden, insbesondere antiseptischen Wirkstoffen und/oder die Wundheilung fördernden Wirkstoffen in den oberen Atemwegen und/oder dem Ohr
AU775500B2 (en) * 1999-05-27 2004-08-05 Euro-Celtique S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
EP1449533A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-iodine liposomes for the treatment of acne

Also Published As

Publication number Publication date
AR043246A1 (es) 2005-07-20
US20130337042A1 (en) 2013-12-19
JP2006518719A (ja) 2006-08-17
WO2004073682A3 (en) 2004-09-23
UY28197A1 (es) 2004-08-31
US20060240089A1 (en) 2006-10-26
WO2004073682A2 (en) 2004-09-02
EP2789331A1 (en) 2014-10-15
US20150313934A1 (en) 2015-11-05
EP1449520A1 (en) 2004-08-25
US20120321695A1 (en) 2012-12-20
EP1596827A2 (en) 2005-11-23

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
EP1594885B8 (de) Medikament zur wachstumsinhibierung von tumoren
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей
GB0416508D0 (en) Therapeutic agents
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
TW200501970A (en) Use of PVP-iodine liposomes for treatment of acne
TW200509987A (en) Use of PVP-iodine liposomes for treatment of Herpes
TW200503778A (en) Use of PVP-iodine liposomes for treatment of atopic dermatitis
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
TW200626588A (en) (Arylamidoaryl)cyanoguanidine compounds
WO2005047278A3 (de) Substituierte dihydrochinazoline ii
AU2003286118A1 (en) Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
TW200513264A (en) Remedy and a therapeutic method for periodontal diseases and pulpal diseases
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.